Systemic lupus erythematosus, All-Cause Mortality, Healthcare Utilization, Anifrolumab, Type I interferon, Belimumab, anti-Blys, anti-BAFF, Biological therapy, Biologics
GLP-1 receptor agonists, inflammatory bowel disease, Cohort study, T2DM
drug abuse, TriNetX network, cohort study
Mild Cognitive Impairment, Dementia, Alzheimer's Disease, Amyloid-β, P-tau181, T-tau, Cerebrospinal Fluid Biomarker, Neuropsychiatric Inventory Questionnaire
Rheumatoid arthritis, glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors, dipeptidyl peptidase-4 inhibitors, basal insulins
cancer incidence, novel agent, proprotein convertase subtilisin/kexin type 9, TriNetX
PCSK9 inhibitor, Erectile dysfunction, Statin, Hyperlipidemia, TriNetX